Anthropometric charts for infants with trisomies 21, 18, or 13 born between 22 weeks gestation and term: The VON charts

Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.
American Journal of Medical Genetics Part A (Impact Factor: 2.16). 02/2012; 158A(2):322-32. DOI: 10.1002/ajmg.a.34423
Source: PubMed


Data on birth weight for gestational age (GA) are not well described for infants with trisomy 21 (T21), trisomy 18 (T18), or trisomy 13 (T13). We report on anthropometric charts of infants with these conditions using data from the Vermont Oxford Network (VON). Data from a total of 5,147 infants with T21 aged 22-41 weeks, 1,053 infants with T18 aged 22-41 weeks, and 613 infants with T13 aged 22-40 weeks were used to create birth weight for GA charts. Head circumference for GA charts were created for infants with T21 only. Combined-sex charts were generated for infants with T18 or T13 while sex-specific charts were generated for infants with T21. Smoothed centiles were created using LmsChartMaker Pro 2.3. Among the three examined groups, infants with T18 were the most likely to be growth restricted while infants with T21 were the least likely to be growth restricted. The new charts for infants with T21 were also compared to the Lubchenco and Fenton charts and both show frequent misclassification of infants with T21 as small or large for GA. The new charts should prove to be useful, especially for infants with T21, to assist in medical management and guide nutrition care decisions.

Download full-text


Available from: Nansi S Boghossian, Oct 05, 2015
40 Reads
  • Source
    American Journal of Medical Genetics Part A 11/2012; 158A(11):2645-6. DOI:10.1002/ajmg.a.35704 · 2.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Aneuploidy is associated with fetal growth restriction already present from the first trimester of pregnancy onwards. With three-dimensional (3D) ultrasound it is possible to measure Embryonic Volume (EV). The innovative 3D Virtual-Reality (VR) approach is a fast and reliable way to measure EV. The relative increase in EV is much larger than that of the CRL over the same time period. We examined whether EV is a better predictor of growth restriction in aneuploid fetuses. Methods: We retrospectively measured CRL and EV in prospectively collected 3D ultrasound volumes of 55 aneuploid fetuses in our Barco I-Space VR system. The gestational age (GA) ranged from 11(+2) to 14(+4) weeks. We compared our measured data with previous published reference curves of euploid fetuses. Delta-values were calculated by subtracting observed values from the expected mean of euploid fetuses of the same GA. The one-sample t-test was performed to test significance. Results: The CRL of fetuses with trisomy 21 (n = 26), trisomy 13 (n = 5) and monosomy X (n = 5) is comparable to those of euploid fetuses. In fetuses with trisomy 18 (n = 19) the CRL is 14.5% smaller (p<0.001). EV in fetuses with trisomy 21, 18, 13 and monosomy X is smaller (respectively -27.8% p<0.001, -39.4% p=<0.001, -40.9 p=0,004 and -27.3% p=0.055). Conclusion: When relying on CRL measurements alone, growth restriction is especially manifest in trisomy 18. Using EV, growth restriction is also evident in trisomy 21, 13 and monosomy X. EV seems to be a more precise parameter to assess first trimester growth restriction in aneuploid fetuses. Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
    Ultrasound in Obstetrics and Gynecology 12/2012; 41(5). DOI:10.1002/uog.12365 · 3.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of the study is to provide data about 22 survivors over the age of 1 year with full trisomy 18 (12-59 months). Mothers completed the online, mixed method Tracking Rare Incidence Syndrome (TRIS) Survey provides data on birth information (e.g., gestational age, birth weight) and medical conditions identified at birth and at the time of survey completion. Data indicate similar birth characteristics to other studies and presence of syndrome related medical conditions including cardiac conditions, use of a variety of feeding methods, apnea, respiratory difficulties, and kidney issues. Associated interventions, sometimes considered "aggressive" or "intensive" treatments including cardiac surgeries were noted in the sample. Implications for treatment are provided and the need for additional research with this clinical subgroup is needed. © 2013 Wiley Periodicals, Inc.
    American Journal of Medical Genetics Part A 03/2014; 164(3). DOI:10.1002/ajmg.a.36318 · 2.16 Impact Factor
Show more